Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-05 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-05 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |